Halozyme to Present Preclinical Data on PEGPH20 at SABCS By: Benzinga via Benzinga December 12, 2014 at 08:03 AM EST Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced that two scientific poster presentations on the pharmacology of PEGPH20 will be ... Read More >> Related Stocks: Halozyme Therapeutic